Pascal Biosciences Inc - ESG Rating & Company Profile powered by AI
Jump to the bottom of the page for potential risks for Pascal Biosciences Inc based on sector, geography and marketcap. Complete ESG analysis of Pascal Biosciences Inc can be reached by signing in. The page contains a zero-cost ESG analysis for Pascal Biosciences Inc.
Pascal Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.9; made up of an environmental score of 0.0, social score of 1.6 and governance score of 4.0.
1.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2150 | Wockhardt Bio AG | 2.0 | Medium |
| 2150 | Yixintang Pharmaceutical Group Co Ltd | 2.0 | Medium |
| ... | ... | ... | |
| 2215 | Pascal Biosciences Inc | 1.9 | Low |
| 2215 | Abnova Taiwan Corp | 1.9 | Low |
| 2215 | Acacia Pharma Group PLC | 1.9 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Pascal Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Pascal Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Pascal Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Pascal Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Pascal Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pascal Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pascal Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Pascal Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Pascal Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Pascal Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pascal Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pascal Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pascal Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pascal Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Pascal Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Pascal Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pascal Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pascal Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Pascal Biosciences Inc., a biotechnology company, researches and develops products for the treatment of cancer, and for the enhancement of immune system. Its development portfolio includes PAS-403, a small molecule therapeutic advancing into clinical trials for the treatment of glioblastoma; and PAS-393, an immuno-stimulatory cannabinoid to be used in combination with checkpoint inhibitor therapy for cancer treatment. The company is also developing a B-cell targeted antibody for acute lymphoblastic leukemia and B cell lymphomas; and cannabinoid therapeutic for the treatment of COVID-19. The company has an exclusive license agreement with the University of Washington to develop a cannabinoid-based product for the treatment of glioblastoma multiforme and brain metastases; and a collaborative research agreement with SoRSE Technology Corporation to advance PAS-393 into clinical testing. Pascal Biosciences Inc. was founded in 2013 and is headquartered in Vancouver, Canada.